Skip to main content

Table 1 Demographics of participants

From: Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients

 

Values

Age (years)

38 (19)

Female (%)

62

Daily dose at week 4 (max) (mg)

103 (38)

DUP (months)

2.1 (0.9)

HAMD17 (baseline)

19.3 (2.8)

Back to article page

Annals of General Psychiatry

ISSN: 1744-859X